Updated December 2020, CMS published a toolkit that catalogs innovative solutions designed at the state level to protect vulnerable nursing home residents during the COVID-19 pandemic...
On September 17, 2020, CMS issued new guidance for visitation in nursing homes during COVID-19. The guidance provides reasonable ways a nursing home can safely facilitate in-person visitation to address the psychosocial needs of residents...
Updated in October 2020, The Job Descriptions for Long-Term Care Facilities will save facilities valuable time and resources, while helping them meet OSHA and ADA requirements.
Two investigational SARS-CoV-2 neutralizing antibody treatments, bamlanivimab and casirivimab plus imdevimab are now available through Emergency Use Authorization (EUA) from the FDA ..
Developed in partnership with ASCP and MED-PASS, this new toolkit is a comprehensive look at the opioid crisis in America, and what pharmacists can do to positively impact patients and prescribers.
